期刊论文详细信息
| Clinical and Experimental Rheumatology | |
| Interleukin-17 inhibition in psoriatic arthritis | |
|   Authors: Tristan Boyd1  Arthur Kavanaugh1  | |
| 关键词: Psoriatic arthritis; clinical trials; interleukin-17; biologics; secukinumab; ixekizumab; brodalumab; | |
| DOI : | |
| 学科分类:医学(综合) | |
| 来源: Pacini Editore SpA | |
PDF
|
|
【 摘 要 】
Greater understanding of the underlying disease process has led to the development of targeted therapeutic agents and innovative strategies in the treatment of psoriatic arthritis (PsA). This report addresses novel medications targeting the T helper 17 cell pathway, specifically those inhibiting interleukin-17A and its receptor, and discusses their role as effective therapies in the management of PsA.
【 授权许可】
Unknown
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| RO201912020417639ZK.pdf | 387KB |
PDF